TEL AVIV, Israel, Dec. 20, 2016 /PRNewswire/
-- Carevature announced
today that its Dreal™ line of products has begun helping surgeons in the US
achieve better outcomes in spinal decompression surgeries. Over 400 patients
worldwide have been treated in clinical use, with outstanding safety and
recovery results. Six centers in Massachusetts, New Hampshire, Connecticut and Texas,
are currently taking part in Dreal™'s limited market release.
Traditional spinal decompression surgeries help patients
with back or limb pain by removing the tissue (usually bone) that's putting
pressure on the spinal nerves. In order to access the problematic tissue,
surrounding tissue often needs to be removed. This can compromise spinal
stability, and may require a spinal fusion procedure to connect the treated
vertebrae and restore stability.
Carevature's Dreal™'s unique curved design enables
orthopedic surgeons and neurosurgeons to perform better spinal decompression
more quickly and with less trauma to the area. Preservation of the surrounding
tissue may reduce the need for spinal fusion procedures or simplify these
procedures when fusion cannot be avoided.
Use of Dreal™ reduces operating room time and
hospitalization time for spinal decompression patients. Spinal decompression
patients treated with Dreal™ can be released from the hospital much faster than
those treated with standard surgical tools. Avoidance of spinal fusion
procedures can save the healthcare system tens of thousands of dollars per
patient.
"I am using the Dreal™ for all my decompression
cases" said Richard Guyer, MD, spine surgeon, co-founder of the Texas
Back Institute in Plano, TX and past president of the North American
Spine Society.
"This is the only device that allows the surgeon to
decompress severely stenotic neuroforamen from the inside out while still
leaving the anatomy intact and eliminating the need for fusion. There
have been other devices but none are as easy to use as this, as it requires no
new skills. While hundreds of thousands of lumbar decompressions are performed
in the US every year, I believe that this device has the potential of reducing
the number of fusions in these patients."
"This is a significant milestone for the entire
Carevature team," said Yosi Weitzman, Carevature Founder and
CEO. "It is exciting to see our hard work and dedication, make a difference
to patients' lives and well-being. We look forward to introducing Dreal™
to more centers as part of our full commercial launch, planned for 2017."
About Carevature
Carevature Medical Ltd. is a privately held medical device
company, dedicated to the development of advanced orthopedic surgery solutions.
Carevature Medical was founded in 2011 and is headquartered in Rehovot, Israel.
Carevature is now focused on its flagship line of products
for spinal indications, Dreal™, the first and only curved device powerful
enough to efficiently cut bone and small enough to be used in spine surgery and
neurosurgery. www.carevature.com
Contact:
Shani Sarid
+972-523392383
Published at PRNewsWire
No comments:
Post a Comment